References
- Levell NJ, Wingfield CG, Garioch JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol 2011; 164:1326-8. https://doi.org/10.1111/j.1365-2133.2011.10275.x PMid:21564054
- Mcnamara DR, Tlyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167(7):709-15. https://doi.org/10.1001/archinte.167.7.709 PMid:17420430
- Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: risk factors: Risikofaktoren für Rezidiverysipele. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2004; 2(2):89-95. https://doi.org/10.1046/j.1439-0353.2004.03028.x PMid:16279242
- Mason JM, Thomas KS, Crook AM, Foster KA, Chalmers JR, Nunn AJ, et al. Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials. PLoS One. 2014; 9:e82694. https://doi.org/10.1371/journal.pone.0082694 PMid:24551029 PMCid:PMC3925077
- Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013; 368:1695e703. https://doi.org/10.1056/NEJMoa1206300 PMid:23635049
- Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A. Comorbidities as Risk Factors for Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019 Mar 30; 7(6):937-942. https://doi.org/10.3889/oamjms.2019.214 PMid:30976336 PMCid:PMC6454161
- Brishkoska-Boshkovski V, Dimitrovska I, Kondova-Topuzovska I. Clinical Presentation and Laboratory Characteristics in Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019 Mar 15; 7(5):771-774. https://doi.org/10.3889/oamjms.2019.213 PMid:30962836 PMCid:PMC6447339
- Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, Jussila T, Syrjanen J: Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clinical Microbiology & Infection. 2010; 16(6):729-34. https://doi.org/10.1111/j.1469-0691.2009.02906.x PMid:19694769
- Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol. 2006;155(5):947-50. https://doi.org/10.1111/j.1365-2133.2006.07419.x PMid:17034523
- Chlebicki MP, Oh CC, Cc O. Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment. Curr Infect Dis Rep 2014;16:422. https://doi.org/10.1007/s11908-014-0422-0 PMid:24980389
- European Dermatology Forum (EDF) S3-Guideline for diagnostics and treatment of venous leg ulcers, Update 2014. http://www.euroderm.org/edf/index.php/edf-guidelines/category/5-guidelines-miscellaneous [accessed July 4, 2016].
- Swartz MN. Cellulitis. N Engl J Med 2004; 350: 904-12. https://doi.org/10.1056/NEJMcp031807 PMid:14985488
- Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, Leibovici L, Paul M. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD009758. https://doi.org/10.1002/14651858.CD009758.pub2 PMid:28631307
- Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. https://doi.org/10.1093/cid/ciu444
- Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N Engl J Med. 2020 Aug 13;383(7):630-639. https://doi.org/10.1056/NEJMoa1917197 PMid:32786188
- Kipsang Joseph, Nangole Wanjala, Khainga Stanley. Compression Therapy in The Management of Cellulitis: A Comparative Study. Journal of Surgery. Vol. 6, No. 3, 2018, pp. 68-72. https://doi.org/10.11648/j.js.20180603.13